Pregnancy Related Clinical Trials in Wilmington, North Carolina

4 studies are recruiting for pregnancy related in Wilmington, North Carolina right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation

    The participants of this study will be of any age who are exposed to at least 1 dose of odevixibat at any time during pregnancy (from 1 day prior to conception to pregnancy outcome) and/or at any time during lactation (up to 12 months of infant age or weaning, whichever comes first. This study will…

    Stage
    Not phased
    Ages
    Any age
    Site
    Virtual Research Coordination Center Odevixibat (BYLVAY) Pregnancy Surveillance Program, Wilmington, North Carolina
    Run by
    Ipsen

    See if you can join NCT06258902 on ClinicalTrials.gov

  2. Elafibranor Pregnancy Surveillance Program: A Study to Evaluate the Safety of Elafibranor During Pregnancy

    The study will include participants who were exposed to at least one dose of elafibranor either within the three weeks before conception or at any time during pregnancy (based on estimated last menstrual period [LMP]). Information will be collected from participants, their healthcare providers, pub…

    Stage
    Not phased
    Ages
    Any age
    Site
    Virtual Research Coordination Center, Wilmington, North Carolina
    Run by
    Ipsen

    See if you can join NCT07556913 on ClinicalTrials.gov

  3. Mavacamten Pregnancy Surveillance Program

    The purpose of this observational pregnancy safety study is to assess maternal, fetal, and infant outcomes after exposure to mavacamten at any time during pregnancy and/or breastfeeding.

    Stage
    Not phased
    Ages
    15 and older
    Site
    The Mavacamten Pregnancy Surveillance Program, PPD Inc, Wilmington, North Carolina
    Run by
    Bristol-Myers Squibb

    See if you can join NCT05939700 on ClinicalTrials.gov

  4. Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring

    The Relugolix Pregnancy Registry is a prospective, observational cohort study designed to evaluate the association between relugolix-containing therapy exposure during pregnancy and subsequent maternal, fetal, and infant outcomes. Data will be collected from enrolled pregnant women and the healthca…

    Stage
    Not phased
    Ages
    0 and older
    Site
    PPD, Wilmington, North Carolina
    Run by
    Sumitomo Pharma Switzerland GmbH

    See if you can join NCT05739123 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.